New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 4, 2013
08:41 EDTSONC, LLY, FINL, FOLD, LULU, ARAY, AUO, FLOn The Fly: Pre-market Movers
HIGHER AFTER GUIDANCE: Eli Lilly (LLY), up 1.7%... ALSO HIGHER: Amicus Theraputics (FOLD), up 8.5% after announcing results from Phase 2 study... AU Optronics (AUO), up 4.7% after DigiTimes said company asked to join Amazon supply chain... LOWER AFTER EARNINGS/GUIDANCE: Finish Line (FINL), down 7%... Sonic (SONC), down 5%... Accuray (ARAY), down 25.5%... ALSO LOWER: Foot Locker (FL), down 2% after disappointing results, guidance of peer Finish Line... lululemon (LULU), down 3.9% after downgrade to Neutral at Credit Suisse.
News For FINL;FL;LULU;LLY;AUO;FOLD;SONC;ARAY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 >>
February 4, 2016
07:56 EDTSONCSONIC, Keurig Green Mountain announce coffee partnership
Subscribe for More Information
February 3, 2016
09:56 EDTLULUlululemon February weekly calls active on renewed takeover chatter
Subscribe for More Information
09:51 EDTLULURumor: lululemon moves up on renewed takeover chatter
Subscribe for More Information
February 1, 2016
06:18 EDTLLYTransition Therapeutics announces results from Phase 2 clinical study of TT401
Subscribe for More Information
06:11 EDTLLYTransition Therapeutics reports results from Phase 2 clinical study of TT401
Subscribe for More Information
January 29, 2016
17:25 EDTLULUlululemon files to sell 9.8M shares of common stock
Subscribe for More Information
05:20 EDTLLYEli Lilly, Adocia initiate Phase 1b study of BioChaperone Lispro U100
Adocia and Eli Lilly announced the initiation of a Phase 1b clinical trial evaluating BioChaperone Lispro, an ultra-rapid formulation of insulin lispro licensed to Lilly. This formulation uses Adocia's proprietary technology, BioChaperone, which is designed to enable the acceleration of insulin absorption. The study, under the Adocia-Lilly partnership, aims to compare the pharmacokinetic and pharmacodynamic profiles of BioChaperone Lispro to that of Humalog in 15 healthy Japanese subjects placed under euglycemic clamp.
January 28, 2016
16:12 EDTARAYAccuray backs FY16 revenue view of $395M-$410M, consensus $404.6M
Adjusted EBITDA is expected to range between $25M-$35M. Accuray continues to expect that gross orders for the fiscal year will be approximately $295M, which would represent a 10% increase year over year. This financial guidance is unchanged from that provided on January 11.
16:11 EDTARAYAccuray reports Q2 EPS (8c), consensus (8c)
Subscribe for More Information
09:55 EDTLLYEli Lilly nears test of key support at $80 area
Subscribe for More Information
06:29 EDTLLYEli Lilly backs FY16 adjusted EPS view of $3.45-$3.55, consensus $3.54
Backs FY16 revenue guidance of $20.2B-$20.7B, consensus $20.83B.
06:27 EDTLLYEli Lilly reports Q4 EPS 78c, consensus 78c
Reports Q4 revenue $5.38B, consensus $5.32B.
January 27, 2016
14:44 EDTLLYEli Lilly volatility elevated into Q4 and outlook
Eli Lilly January weekly call option implied volatility is at 54, February is at 29; compared to its 52-week range of 15 to 41, suggesting large near term price movement into the expected release of Q4 results on January 28.
14:34 EDTLLYNotable companies reporting before tomorrow's open
Subscribe for More Information
09:02 EDTLLYEli Lilly and Roche to collaborate on Alzheimer's diagnostic tool
Subscribe for More Information
January 26, 2016
09:09 EDTLULUlululemon moves up in pre-market
Subscribe for More Information
06:30 EDTFLFoot Locker added to US 1 List at BofA/Merrill
BofA/Merrill added Foot Locker (FL) to the US 1 List and said Nike's (NKE) innovation in casual athletic should support solid comps. Additionally, Foot Locker will likely receive favorable allocations from Nike given Under Armour's focus and momentum in the mall channel.
January 25, 2016
17:14 EDTLULULone Pine Capital reports 5.0% passive stake in lululemon
08:36 EDTLLYFDA accepts supplemental NDA for Eli Lilly and Boehringer's Jardiance
Subscribe for More Information
07:02 EDTLULUlululemon can take prices higher, says Jefferies
Subscribe for More Information
1 | 2 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use